{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:32:39Z","timestamp":1788993159195,"version":"build-2803163510"},"reference-count":41,"publisher":"Japan Endocrine Society","issue":"6","funder":[{"name":"fund of Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0622","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T22:11:12Z","timestamp":1740521472000},"page":"671-687","source":"Crossref","is-referenced-by-count":8,"title":["Association of uric acid levels with the development of metabolic dysfunction-associated and metabolic and alcohol-related\/associated steatotic liver disease: a study on Japanese participants undergoing health checkups"],"prefix":"10.1507","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7468-317X","authenticated-orcid":false,"given":"Tatsuya","family":"Fukuda","sequence":"first","affiliation":[{"name":"Mirraza Shinjuku Tsurukame Clinic, Tokyo 160-0022, Japan"},{"name":"Department of Endocrinology and Metabolism, Tokyo Metropolitan Okubo Hospital, Tokyo 160-8488, Japan"},{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo 113-8510, Japan"},{"name":"Shinjuku Tsurukame Clinic, Tokyo 151-0053, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Akihisa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Tokyo Metropolitan Okubo Hospital, Tokyo 160-8488, Japan"},{"name":"Shinjuku Tsurukame Clinic, Tokyo 151-0053, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Mirraza Shinjuku Tsurukame Clinic, Tokyo 160-0022, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukaishi","sequence":"additional","affiliation":[{"name":"Koganei Tsurukame Clinic, Tokyo 184-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Shinjuku Tsurukame Clinic, Tokyo 151-0053, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Koganei Tsurukame Clinic, Tokyo 184-0004, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo 113-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koshiro","family":"Monzen","sequence":"additional","affiliation":[{"name":"Shinjuku Tsurukame Clinic, Tokyo 151-0053, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1 Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, et al. (2016) Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64: 73\u201384.","DOI":"10.1002\/hep.28431"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Wang XJ, Malhi H (2018) Nonalcoholic fatty liver disease. Ann Intern Med 169: ITC65\u2013ITC80.","DOI":"10.7326\/AITC201811060"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Tomic D, Kemp WW, Roberts SK (2018) Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies. Eur J Gastroenterol Hepatol 30: 1103\u20131115.","DOI":"10.1097\/MEG.0000000000001235"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4 Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, et al. (2023) The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77: 1335\u20131347.","DOI":"10.1097\/HEP.0000000000000004"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Younossi ZM (2019) Non-alcoholic fatty liver disease\u2014A global public health perspective. J Hepatol 70: 531\u2013544.","DOI":"10.1016\/j.jhep.2018.10.033"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6 Ge X, Zheng L, Wang M, Du Y, Jiang J (2020) Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990\u20132017: a population-based observational study. BMJ Open 10: e036663.","DOI":"10.1136\/bmjopen-2019-036663"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Idalsoaga F, Kulkarni AV, Mousa OY, Arrese M, Arab JP (2020) Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities. Front Med (Lausanne) 7: 448.","DOI":"10.3389\/fmed.2020.00448"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8 Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, et al. (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78: 1966\u20131986.","DOI":"10.1097\/HEP.0000000000000520"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Valenti L, Bugianesi E, Pajvani U, Targher G (2016) Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes? Liver Int 36: 1563\u20131579.","DOI":"10.1111\/liv.13185"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10 Muzurovi\u0107 E, Mikhailidis DP, Mantzoros C (2021) Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism 119: 154770.","DOI":"10.1016\/j.metabol.2021.154770"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Bombelli M, Quarti-Trevano F, Tadic M, Facchetti R, Cuspidi C, et al. (2018) Uric acid and risk of new-onset metabolic syndrome, impaired fasting glucose and diabetes mellitus in a general Italian population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study. J Hypertens 36: 1492\u20131498.","DOI":"10.1097\/HJH.0000000000001721"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Li C, Hsieh MC, Chang SJ (2013) Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol 25: 210\u2013216.","DOI":"10.1097\/BOR.0b013e32835d951e"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Ali N, Miah R, Hasan M, Barman Z, Mou AD, et al. (2020) Association between serum uric acid and metabolic syndrome: a cross-sectional study in Bangladeshi adults. Sci Rep 10: 7841.","DOI":"10.1038\/s41598-020-64884-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O (2012) Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol 176: 108\u2013116.","DOI":"10.1093\/aje\/kws002"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Utzschneider KM, Kahn SE (2006) Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91: 4753\u20134761.","DOI":"10.1210\/jc.2006-0587"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Sun Q, Zhang T, Manji L, Liu Y, Chang Q, et al. (2023) Association between serum uric acid and non-alcoholic fatty liver disease: an updated systematic review and meta-analysis. Clin Epidemiol 15: 683\u2013693.","DOI":"10.2147\/CLEP.S403314"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17 Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, et al. (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43: 1317\u20131325.","DOI":"10.1002\/hep.21178"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Fukuda T, Okamoto T, Fukaishi T, Kawakami A, Tanaka M, et al. (2024) Extent to which weight loss contributes to improving metabolic dysfunction-associated and metabolic and alcohol related\/associated steatotic liver disease: a study on Japanese participants undergoing health checkups. Front Endocrinol (Lausanne) 15: 1392280.","DOI":"10.3389\/fendo.2024.1392280"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, et al. (2006) The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6: 33.","DOI":"10.1186\/1471-230X-6-33"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 The Examination Committee of Criteria for \u2018Obesity Disease\u2019 in Japan; Japan Society for the Study of Obesity  (2002) New criteria for \u2018obesity disease\u2019 in Japan. Circ J 66: 987\u2013992.","DOI":"10.1253\/circj.66.987"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Fluss R, Faraggi D, Reiser B (2005) Estimation of the Youden index and its associated cutoff point. Biom J 47: 458\u2013472.","DOI":"10.1002\/bimj.200410135"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Hak AE, Choi HK (2008) Menopause, postmenopausal hormone use and serum uric acid levels in US women\u2014the third national health and nutrition examination survey. Arthritis Res Ther 10: R116.","DOI":"10.1186\/ar2519"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Kamada Y, Fujii H, Suzuki Y, Sawada K, Tatsuta M, et al. (2024) Clinical characteristics of steatotic liver disease categories in a large cohort of Japanese health checkup participants. Gastro Hep Adv 3: 1148\u20131156.","DOI":"10.1016\/j.gastha.2024.08.006"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Suzuki K, Tamaki N, Kurosaki M, Takahashi Y, Yamazaki Y, et al. (2024) Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease. Hepatol Res 54: 600\u2013605.","DOI":"10.1111\/hepr.14011"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25 Seko Y, Lin H, Wong VW, Okanoue T (2024) Impact of PNPLA3 in Lean Individuals and in Cryptogenic Steatotic Liver Disease. Liver Int doi: 10.1111\/liv.16164. Online ahead of print.","DOI":"10.1111\/liv.16164"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Xu C, Yu C, Xu L, Miao M, Li Y (2010) High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study. PLoS One 5: e11578.","DOI":"10.1371\/journal.pone.0011578"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Lee JW, Cho YK, Ryan M, Kim H, Lee SW, et al. (2010) Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver 4: 378\u2013383.","DOI":"10.5009\/gnl.2010.4.3.378"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Wei F, Li J, Chen C, Zhang K, Cao L, et al. (2020) Higher serum uric acid level predicts non-alcoholic fatty liver disease: a 4-year prospective cohort study. Front Endocrinol (Lausanne) 11: 179.","DOI":"10.3389\/fendo.2020.00179"},{"key":"29","unstructured":"29 Darmawan G, Hamijoyo L, Hasan I (2017) Association between serum uric acid and non-alcoholic fatty liver disease: a meta-analysis. Acta Med Indones 49: 136\u2013147."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Wijarnpreecha K, Panjawatanan P, Lekuthai N, Thongprayoon C, Cheungpasitporn W, et al. (2017) Hyperuricaemia and risk of nonalcoholic fatty liver disease: a meta-analysis. Liver Int 37: 906\u2013918.","DOI":"10.1111\/liv.13329"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 He L, Qiu K, Zheng W, Kong W, Zeng T (2024) Uric acid may serve as the sixth cardiometabolic criterion for defining MASLD. J Hepatol 80: e152\u2013e153.","DOI":"10.1016\/j.jhep.2023.12.009"},{"key":"32","unstructured":"32 Long MT (2022) Alcohol consumption and nonalcoholic steatohepatitis\/nonalcoholic fatty liver disease. Gastroenterol Hepatol (N Y) 18: 491\u2013493."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Li Z, Guo X, Liu Y, Chang Y, Sun Y, et al. (2016) The relation of moderate alcohol consumption to hyperuricemia in a rural general population. Int J Environ Res Public Health 13: 732.","DOI":"10.3390\/ijerph13070732"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Choi YJ, Shin HS, Choi HS, Park JW, Jo I, et al. (2014) Uric acid induces fat accumulation <i>via<\/i> generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. Lab Invest 94: 1114\u20131125.","DOI":"10.1038\/labinvest.2014.98"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Zhi L, Yuzhang Z, Tianliang H, Hisatome I, Yamamoto T, et al. (2016) High uric acid induces insulin resistance in cardiomyocytes <i>in vitro<\/i> and <i>in vivo<\/i>. PLoS One 11: e0147737.","DOI":"10.1371\/journal.pone.0147737"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Wan X, Xu C, Lin Y, Lu C, Li D, et al. (2016) Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol 64: 925\u2013932.","DOI":"10.1016\/j.jhep.2015.11.022"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Lanaspa MA, Cicerchi C, Garcia G, Li N, Roncal-Jimenez CA, et al. (2012) Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver. PLoS One 7: e48801.","DOI":"10.1371\/journal.pone.0048801"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Tanaka Y, Nagoshi T, Takahashi H, Oi Y, Yoshii A, et al. (2022) URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice. Mol Metab 55: 101411.","DOI":"10.1016\/j.molmet.2021.101411"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Li S, Fu Y, Liu Y, Zhang X, Li H, et al. (2022) Serum uric acid levels and nonalcoholic fatty liver disease: a 2-sample bidirectional mendelian randomization study. J Clin Endocrinol Metab 107: e3497\u2013e3503.","DOI":"10.1210\/clinem\/dgac190"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Khov N, Sharma A, Riley TR (2014) Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol 20: 6821\u20136825.","DOI":"10.3748\/wjg.v20.i22.6821"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Livingston M, Callinan S (2015) Underreporting in alcohol surveys: whose drinking is underestimated? J Stud Alcohol Drugs 76: 158\u2013164.","DOI":"10.15288\/jsad.76.1.158"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/6\/72_EJ24-0622\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:41:42Z","timestamp":1749271302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/6\/72_EJ24-0622\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0622","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0622"}}